Healthcare
Live Price
Offline$0.0003
+0.00% today
1Y Change
+50.00%
Window
Jun 23, 2025 → Jun 19, 2026
Coverage: 250 bars · Jun 23, 2025 → Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
UpHealth, Inc. (UPHL) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.00 and up 50.0% across the available one-year price window (Jun 23, 2025 → Jun 19, 2026). Baseline metrics include revenue growth of -18.1%, EPS growth of +78.5%, a dividend yield of 0.0%. What stands out right now is revenue -18.1%, EPS +78.5%, free cash flow +26.1% with operating margin -15.8% and ROIC -8.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UPHL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UPHL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UPHL Max Drawdown
-75.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UPHL and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
$360.5K
+116.5% YoY
Free Cash Flow
-$1.5M
-29.7% YoY
Revenue Growth
-18.1%
EPS Growth
+78.5%
Gross Margin
44.2%
Net Margin
-140.4%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 130M | 159M | 124M | 5M | 0 |
| Gross Profit | 70M | 54M | 31M | 4M | 0 |
| Operating Income | -90M | -25M | -45M | -2M | -953K |
| EBITDA | -17M | -184M | -306M | -2M | -953K |
| Net Income | -58M | -223M | -341M | -2M | 360K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 16M | 77M | 2M | 2M |
| Total Assets | 232M | 340M | 569M | 262M | 176M |
| Total Liabilities | 177M | 234M | 235M | 42M | 340K |
| Shareholder Equity | 55M | 105M | 318M | 221M | 175M |
| Total Debt | 153M | 160M | 127M | 23M | 0 |
| Net Debt | 151M | 145M | 45M | 21M | -2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
-29.7% YoY
Capital Expenditures
0
Free Cash Flow
1M
-29.7% YoY
Key ratios
Gross Margin
44.2%
Operating Margin
-15.8%
Net Margin
-140.4%
ROE
-105.3%
Debt / Equity
1.50x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.